Literature DB >> 20517292

Pathophysiology and treatment of cystinuria.

Josep Chillarón1, Mariona Font-Llitjós, Joana Fort, Antonio Zorzano, David S Goldfarb, Virginia Nunes, Manuel Palacín.   

Abstract

Cystinuria is a primary inherited aminoaciduria caused by mutations in the genes that encode the two subunits (neutral and basic amino acid transport protein rBAT and b(0,+)-type amino acid transporter 1) of the amino acid transport system b(0,+). This autosomal recessive disorder (in which few cases show dominant inheritance) causes a failure in the reabsorption of filtered cystine and dibasic amino acids in the proximal tubule. The clinical symptoms of this disease are caused by the loss of poorly soluble cystine, which precipitates to form stones. Although rare, the prevalence of cystinuria is sufficiently high that the disease results in a substantial contribution to pediatric renal lithiasis. A thorough understanding of cystine transport processes over the past 15 years and the genetic abnormalities responsible for the disease has led to a new classification of cystinuria and recognition that some cases result from an autosomal dominant etiology with incomplete penetrance. This Review examines the molecular and mechanistic effects of some of the mutations that cause cystinuria based on our current understanding of the structural and cellular biology of system b(0,+). This Review also describes the current treatments to prevent recurrent cystine lithiasis.

Entities:  

Mesh:

Year:  2010        PMID: 20517292     DOI: 10.1038/nrneph.2010.69

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  135 in total

1.  Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease.

Authors:  Raquel L Lieberman; Brandon A Wustman; Pedro Huertas; Allan C Powe; Corey W Pine; Richie Khanna; Michael G Schlossmacher; Dagmar Ringe; Gregory A Petsko
Journal:  Nat Chem Biol       Date:  2006-12-24       Impact factor: 15.040

2.  Anticystinuric effects of glutamine and of dietary sodium restriction.

Authors:  P Jaeger; L Portmann; A Saunders; L E Rosenberg; S O Thier
Journal:  N Engl J Med       Date:  1986-10-30       Impact factor: 91.245

3.  Functional and structural characterization of the first prokaryotic member of the L-amino acid transporter (LAT) family: a model for APC transporters.

Authors:  Núria Reig; César del Rio; Fabio Casagrande; Mercè Ratera; Josep Lluís Gelpí; David Torrents; Peter J F Henderson; Hao Xie; Stephen A Baldwin; Antonio Zorzano; Dimitrios Fotiadis; Manuel Palacín
Journal:  J Biol Chem       Date:  2007-03-06       Impact factor: 5.157

4.  Evidence for association of SLC7A9 gene haplotypes with cystinuria manifestation in SLC7A9 mutation carriers.

Authors:  Anthoula Chatzikyriakidou; Nikolaos Sofikitis; Vasiliki Kalfakakou; Konstantinos Siamopoulos; Ioannis Georgiou
Journal:  Urol Res       Date:  2006-07-13

5.  Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.

Authors:  D Torrents; J Mykkänen; M Pineda; L Feliubadaló; R Estévez; R de Cid; P Sanjurjo; A Zorzano; V Nunes; K Huoponen; A Reinikainen; O Simell; M L Savontaus; P Aula; M Palacín
Journal:  Nat Genet       Date:  1999-03       Impact factor: 38.330

6.  Cystinuria: biochemical evidence for three genetically distinct diseases.

Authors:  L E Rosenberg; S Downing; J L Durant; S Segal
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

7.  Global distribution of the most prevalent deletions causing hypotonia-cystinuria syndrome.

Authors:  Kevin Martens; Inge Heulens; Sandra Meulemans; Marco Zaffanello; David Tilstra; Frederik J Hes; Raoul Rooman; Inge François; Francis de Zegher; Jaak Jaeken; Gert Matthijs; John W M Creemers
Journal:  Eur J Hum Genet       Date:  2007-06-20       Impact factor: 4.246

8.  CD98hc facilitates B cell proliferation and adaptive humoral immunity.

Authors:  Joseph Cantor; Cecille D Browne; Raphael Ruppert; Chloé C Féral; Reinhard Fässler; Robert C Rickert; Mark H Ginsberg
Journal:  Nat Immunol       Date:  2009-03-08       Impact factor: 25.606

9.  Cystinuria-specific rBAT(R365W) mutation reveals two translocation pathways in the amino acid transporter rBAT-b0,+AT.

Authors:  Marta Pineda; Carsten A Wagner; Angelika Bröer; Paul A Stehberger; Simone Kaltenbach; Josep Ll Gelpí; Rafael Martín Del Río; Antonio Zorzano; Manuel Palacín; Florian Lang; Stefan Bröer
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

10.  Mutations in the genomic deoxyribonucleic acid for SLC3A1 in patients with cystinuria.

Authors:  W L Gitomer; B Y Reed; L A Ruml; K Sakhaee; C Y Pak
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

View more
  64 in total

1.  Urine proteomic profiling in patients with nephrolithiasis and cystinuria.

Authors:  Larisa Kovacevic; Joseph A Caruso; Hong Lu; Natalija Kovacevic; Yegappan Lakshmanan; Nicholas J Carruthers; David S Goldfarb
Journal:  Int Urol Nephrol       Date:  2018-12-05       Impact factor: 2.370

2.  Lysine triggers apoptosis through a NADPH oxidase-dependent mechanism in human renal tubular cells.

Authors:  Daniela Verzola; Annamaria Famà; Barbara Villaggio; Maia Di Rocco; Alchiede Simonato; Elena D'Amato; Fabio Gianiorio; Giacomo Garibotto
Journal:  J Inherit Metab Dis       Date:  2012-03-09       Impact factor: 4.982

Review 3.  Cystine growth inhibition through molecular mimicry: a new paradigm for the prevention of crystal diseases.

Authors:  Michael H Lee; Amrik Sahota; Michael D Ward; David S Goldfarb
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

Review 4.  Potential pharmacologic treatments for cystinuria and for calcium stones associated with hyperuricosuria.

Authors:  David S Goldfarb
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-14       Impact factor: 8.237

Review 5.  Stable isotope dilution mass spectrometry for membrane transporter quantitation.

Authors:  Vahid Farrokhi; Adam J McShane; Reza Nemati; Xudong Yao
Journal:  AAPS J       Date:  2013-10       Impact factor: 4.009

6.  Clinical utility gene card for: Cystinuria.

Authors:  Thomas Eggermann; Klaus Zerres; Virginia Nunes; Mariona Font-Llitjós; Luigi Bisceglia; Anthoula Chatzikyriakidou; Luca dello Strologo; Elon Pras; John Creemers; Manuel Palacin
Journal:  Eur J Hum Genet       Date:  2011-08-24       Impact factor: 4.246

7.  Cystinuria in a patient with 19q12q13.1 deletion.

Authors:  Teresa de Rojas; Cristina Aparicio; Carmen de Lucas; Beatriz Martinez; Belén Gil-Fournier; Soraya Ramiro-León
Journal:  CEN Case Rep       Date:  2015-09-19

8.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

9.  Synergistic mutations in SLC3A1 and SLC7A9 leading to heterogeneous cystinuria phenotypes: pitfalls in the diagnostic workup.

Authors:  Sebastian Kummer; Andreas Venghaus; Andrea Schlune; Barbara Leube; Thomas Eggermann; Ute Spiekerkoetter
Journal:  Pediatr Nephrol       Date:  2013-09-19       Impact factor: 3.714

Review 10.  How should patients with cystine stone disease be evaluated and treated in the twenty-first century?

Authors:  Kim Hovgaard Andreassen; Katja Venborg Pedersen; Susanne Sloth Osther; Helene Ulrik Jung; Søren Kissow Lildal; Palle Joern Sloth Osther
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.